Nouveau Medicament Private Limited, a active private limited company, was established on 17 April 2001 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231TN2001PTC046971. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹4.10 Cr and a paid-up capital of ₹1.48 Cr.
It upholds a compliant status. Employing 278 professional, Its leadership includes Uma Ramaswamy Iyer (Whole-Time Director), Bhagyalakshmi Gowrishankar (Whole-Time Director), Raamganesh Samakkulam (Managing Director). Past directors included Ramaswamy Samakkulam Ramalingam Iyer, Uma Ramaswamy Iyer, Bhagyalakshmi Gowrishankar. It holds no open charges and ₹0.62 M settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at New No.: 720, Anna Salai , Nandanam,, Chennai, Tamil Nadu, 600035.
U24231TN2001PTC046971
046971
17 April 2001
₹4.10 Cr
₹1.48 Cr
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Nouveau Medicament Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Uma Ramaswamy Iyer | Whole-Time Director | 17 Apr 2001 | Current |
| Bhagyalakshmi Gowrishankar | Whole-Time Director | 23 Feb 2011 | Current |
| Raamganesh Samakkulam | Managing Director | 02 Mar 2009 | Current |
| Ramanan Kalyanavenkita Ramalingam | Whole-Time Director | 02 Mar 2009 | Current |
| Neeraja Ramakrishnan | Director | 02 Mar 2009 | Current |
| Karthikraman Samakulam | Whole-Time Director | 02 Mar 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 23 Jan 2014 | Past |
| Pramod Abcsdd | Director | 23 Jan 2014 | Past |
| Pramod Abcsdd | Director | 23 Jan 2014 | Past |
| Pramod Abcsdd | Additional Director | 27 Jul 2009 | Past |
| Pramod Abcsdd | Additional Director | 27 Jul 2009 | Past |
| Pramod Abcsdd | Whole-Time Director | 01 Sep 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nouveau Medicament Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.62% decrease. The company also saw a substantial fall in profitability, with a 65.95% decrease in profit. The company's net worth moved up by a moderate rise of 3.82%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Nouveau Medicament had a promoter holding of 91.39% and a public holding of 8.61%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹620,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Sep 2004 | Uco Bank | ₹0.62 M | Satisfied |
Explore comprehensive loan charge details -
Nouveau Medicament has a workforce of 278 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Nouveau Medicament, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nouveau Medicament's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Nouveau Medicament Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was completed.
The activity Nouveau Medicament Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was completed.
Progress on A charge registered on 24 Sep 2004 via Charge ID 90295109 with Uco Bank was fully satisfied on 11 Oct 2018. was documented.
Progress on Bhagyalakshmi Gowrishankar was appointed as a Whole-time director was appointed as a Whole-time director on 23 Feb 2011 & has been associated with this company since 14 years 9 months . was documented.
The activity Raamganesh Samakkulam was appointed as a Managing Director was appointed as a Managing Director on 02 Mar 2009 & has been associated with this company since 16 years 9 months . was completed.
The activity Ramanan Kalyanavenkita Ramalingam was appointed as a Whole-time director was appointed as a Whole-time director on 02 Mar 2009 & has been associated with this company since 16 years 9 months . was completed.
The CIN of Nouveau Medicament Private Limited is U24231TN2001PTC046971.
Nouveau Medicament Private Limited is headquartered at New No.: 720, Anna Salai , Nandanam,, Chennai, Tamil Nadu, 600035.
Nouveau Medicament Private Limited was incorporated on 17 April 2001.
The current directors of Nouveau Medicament Private Limited are
The primary industry of Nouveau Medicament Private Limited is Manufacturing.
Nouveau Medicament Private Limited is unlisted.
The authorized capital of Nouveau Medicament Private Limited is ₹4.10 Cr, and the paid-up capital is ₹1.48 Cr.
The compliance status of Nouveau Medicament Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX